Patent details

EP3902541 Title: THERAPEUTIC COMPOSITIONS COMPRISING DEUTERATED OR PARTIALLY DEUTERATED N,N-DIMETHYLTRYPTAMINE COMPOUNDS

Basic Information

Publication number:
EP3902541
PCT Application Number:
EP2021060750
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP217205095
PCT Publication Number:
WO2021116503
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
THERAPEUTIC COMPOSITIONS COMPRISING DEUTERATED OR PARTIALLY DEUTERATED N,N-DIMETHYLTRYPTAMINE COMPOUNDS
French Title of Invention:
COMPOSITIONS THÉRAPEUTIQUES COMPRENANT DES COMPOSÉS DE N,N-DIMETHYLTRYPTAMINE DEUTÉRÉS OU PARTIELLEMENT DEUTÉRÉS
German Title of Invention:
THERAPEUTISCHE ZUSAMMENSETZUNGEN, DIE DEUTERIERTE ODER TEILDEUTERIERTE N,N-DIMETHYLTRYPTAMIN-VERBINDUNGEN ENTHALTEN
SPC Number:

Dates

Filing date:
23/04/2021
Grant date:
14/09/2022
EP Publication Date:
03/11/2021
PCT Publication Date:
17/06/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/09/2022
EP B1 Publication Date:
14/09/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/04/2023
Expiration date:
23/04/2041
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/09/2022
 
 

Name:
Small Pharma Ltd
Address:
6-8 Bonhill Street, London EC2A 4BX, United Kingdom (GB)

Inventor

1

Name:
JOEL, Zelah
Address:
United Kingdom (GB)

2

Name:
RANDS, Peter
Address:
United Kingdom (GB)

3

Name:
JAMES, Ellen
Address:
United Kingdom (GB)

4

Name:
BENWAY, Tiffanie
Address:
United Kingdom (GB)

5

Name:
LAYZELL, Marie
Address:
United Kingdom (GB)

Priority

1

Priority Number:
202008303
Priority Date:
02/06/2020
Priority Country:
United Kingdom (GB)

2

Priority Number:
PCT/EP2020/065244
Priority Date:
02/06/2020
Priority Country:
World Intellectual Property Office (WIPO) (WO)

3

Priority Number:
202016890664
Priority Date:
02/06/2020
Priority Country:
United States (US)

4

Priority Number:
202017108679
Priority Date:
01/12/2020
Priority Country:
United States (US)

5

Priority Number:
202018955
Priority Date:
01/12/2020
Priority Country:
United Kingdom (GB)

6

Priority Number:
202017108938
Priority Date:
01/12/2020
Priority Country:
United States (US)

7

Priority Number:
202018950
Priority Date:
01/12/2020
Priority Country:
United Kingdom (GB)

8

Priority Number:
202117208583
Priority Date:
22/03/2021
Priority Country:
United States (US)

9

Priority Number:
202103981
Priority Date:
22/03/2021
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 31/4045; A61P 25/18; A61P 25/22; A61P 25/24; A61P 25/30; C07D 209/16; A61P 25/00; A61K 9/20; A61K 9/48; A61K 45/06;

Publication

European Patent Bulletin

Issue number:
202237
Publication date:
14/09/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages